Dr. Christopher Rogers and Dr. Mary Ambach from the San Diego Orthobiologics Medical Group are one of only 10 sites treating patients in a multi-center clinical trial for the treatment of knee osteoarthritis using a patient’s own fat-derived stem cells. Personalized Stem Cells, Inc is sponsoring the FDA approved clinical trial, which is the FIRST EVER in the United States to study the use of a patient’s own fat-derived stem cells processed and tested in a centralized FDA inspected manufacturing lab. In addition to treating knee osteoarthritis, the patient’s stem cells may be stored in this facility and potentially used for the treatment of other medical conditions in future approved clinical trials.
Information about the clinical trial can be found here.
Check for updates regarding the study and the recruitment process on our website, SDOMG.com
DataBiologics launched their world-wide Regenerative Medicine Registry at the Orthobiologics Institute (TOBI) annual conference in Chicago last week.
Founders Dr. Christopher Rogers, Dr. Gerald Malanga and Dr. Jay Bowen attended the conference and were excited to see the huge interest in collecting patient reported outcome.
DataBiologics is simple to use, practical and affordable which allows Regenerative Medicine physicians to track their patient outcomes and collaborate with other physicians from around the world.
Dr. Chris Rogers and Dr. Gerald Malanga, co-founders of DataBiologics met with Dr. Arnold Caplan (middle) at TOBI last week. Dr. Caplan was the first scientist to discover, characterize and name the Mesenchymal Stem Cell in 1991. All doctors agree that now is the time to collect meaningful data, so that we can advance the field of Regenerative Medicine.
The Orthobiologic Institute (TOBI) founder, Dr. Steven Sampson shares a glass of champagne with DataBiologics co-founders, Dr. Jay Bowen, Dr. Gerald Malanga and Dr. Chris Rogers.
DataBiologics made its debut last week at the TOBI annual conference in Chicago. Physicians who join the Orthohealing Method Network will also receive access to the DataBiologics Registry.
Executive Director, Linda Rivord-Gutierrez and Patricia Rogers were on hand at TOBI last week to share all the exciting news about the new DataBiologics Registry.
The Orthobiologic Institute (TOBI) is the most widely recognized regenerative symposium and is attended by hundreds of physicians and specialists from all over the world. Dr Rogers and Dr Ambach were presenters and faculty to the 10th annual TOBI symposium in Chicago where cutting edge research and latest evidence on PRP and stem cell treatments were presented and discussed.
Dr Chris Rogers and Dr Mary Ambach along with fellow skilled specialists served as faculty at the Orthobiologic Institute Symposium and Workshops in Chicago on June 6, 2019.
Dr Rogers and Dr Ambach lectured on Lipoaspirate and Interventional Spine literature, science, techniques and proctored in the cadaver workshop lab to teach physicians from all over the world on injection techniques.
SDOMG Doctors Give Free Education on Safe and Proper Stem Cell Therapies
Dr. Chris Rogers and Dr. Mary Ambach had a successful seminar on natural regenerative treatments a few weeks ago at the BREG facility in Carlsbad. Attendees learned how cutting-edge nonsurgical treatments, like platelet-rich plasma, bone marrow concentrate stem cells and adipose or fat cells can be safely utilized to help heal orthopedic and sports injuries.
If you missed this exciting informative discussion, make sure to attend the next one.
The newest addition to our team, Dr. Mary Ambach, is one of the symposium speakers and faculty at the prestigious PRP Seminar June 6-8 in Chicago.
Dr. Ambach’s primary focus is non-operative spine and joint care utilizing fluoroscopic (x-ray) and musculoskeletal ultrasound guided procedures to perform state-of-the-art treatments such as Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC).
The seminar is in its 10th year. The Orthobiologic Institute was founded to share best practices in biologics research and orthopedic applications. TOBI promotes a high-quality, standardized approach to biologic treatments, to advance the field, and gain recognition as viable, effective treatment.
Dr. Christopher Rogers and Dr. Mary Ambach from the San Diego Orthobiologics Medical Group are one of only 10 sites treating patients in a multi-center clinical trial for the treatment of knee osteoarthritis using a patient’s own fat-derived stem cells. Personalized Stem Cells, Inc is sponsoring the FDA approved clinical trial, which is the FIRST EVER in the United States to study the use of a patient’s own fat-derived stem cells processed and tested in a centralized FDA inspected manufacturing lab. In addition to treating knee osteoarthritis, the patient’s stem cells may be stored in this facility and potentially used for the treatment of other medical conditions in future approved clinical trials.
